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Interactions among the three structural domains of Bacillus thuringiensis Cry1 toxins were investigated by
functional analysis of chimeric proteins. Hybrid genes were prepared by exchanging the regions coding for
either domain I or domain III among Cry1Ab, Cry1Ac, Cry1C, and Cry1E. The activity of the purified trypsin-
activated chimeric toxins was evaluated by testing their effects on the viability and plasma membrane perme-
ability of Sf9 cells. Among the parental toxins, only Cry1C was active against these cells and only chimeras
possessing domain II from Cry1C were functional. Combination of domain I from Cry1E with domains II and
III from Cry1C, however, resulted in an inactive toxin, indicating that domain II from an active toxin is
necessary, but not sufficient, for activity. Pores formed by chimeric toxins in which domain I was from Cry1Ab
or Cry1Ac were slightly smaller than those formed by toxins in which domain I was from Cry1C. The properties
of the pores formed by the chimeras are therefore likely to result from an interaction between domain I and
domain II or III. Domain III appears to modulate the activity of the chimeric toxins: combination of domain
III from Cry1Ab with domains I and II of Cry1C gave a protein which was more strongly active than Cry1C.
Bacillus thuringiensis produces a crystalline inclusion body
containing highly specific insecticidal proteins, also called d-en-
dotoxins, which may vary, depending on the bacterial strain, in
both number and type (5, 19, 43). Their mode of action in-
volves a cascade of events including solubilization of the crys-
tal, activation of the toxins by gut proteases, and recognition of
a binding site on the midgut brush border membrane, followed
by pore formation, membrane transport disruption, and cell
lysis, ultimately leading to insect death (12, 17, 23, 43).
The three-dimensional structures of three insecticidal crystal
proteins, Cry1Aa, Cry3A, and CytB, have been elucidated by
X-ray diffraction analysis (18, 31, 32). The activated Cry1Aa
and Cry3A proteins are remarkably similar with respect to
their overall structures, and they share three structural do-
mains (18, 31). Domain I, located at the N-terminal end of the
activated protein, is made of a bundle of eight hydrophobic and
amphipathic a-helices, whereas domains II and III are made
mostly of b-sheets. Domain I is thought to be responsible for
pore formation in the epithelial cell membrane. A number of
mutations in domain I abolish or reduce the toxicity of the
protein without affecting its binding properties significantly (1,
7, 21, 60). N-terminal fragments of Cry1Ac (57) and Cry3B
(56) have been shown to form channels in liposomes and pla-
nar lipid bilayer membranes. Experiments in which fragments
from different closely related toxins were exchanged have lo-
calized the specificity-determining and receptor-binding do-
mains of a number of toxins to domain II (15, 16, 27, 33, 35,
50, 58). Site-directed mutagenesis experiments have further
stressed the importance of three domain II surface-exposed
loops situated at the apex of the molecule in receptor recog-
nition (28, 34, 38–40, 48, 49, 61). Domain III is also involved in
specificity, since mutations in this domain which affect toxicity
and binding have been described (2). In addition, full insecti-
cidal activity often requires the presence of sequences from
both domains II and III of an active toxin (15, 20, 44). Ex-
change of domain III between different insecticidal proteins
also often results in host range modifications and changes in
the membrane proteins to which the toxins bind (3, 10, 11, 29,
35).
Models have been proposed to explain channel formation
(14, 23, 24, 31, 46), but experimental evidence is lacking to
clearly demonstrate the exact involvement of each toxin do-
main in the overall toxic process. The different domains appear
to influence each other to some extent, since mutations in
domain I which affect binding have been described (60), as well
as mutations in domain II which affect toxicity without signif-
icantly affecting overall binding (37, 48). Mutant Cry3A with an
altered domain II loop 3 even had reduced binding but in-
creased toxicity (61). Mutations in highly conserved block 4 of
domain III which affect toxicity and pore formation have also
been described (8, 47, 59). Some of these were, in addition,
shown to have no significant effect on initial binding (8).
We report here the effect of domain swapping on pore for-
mation and membrane permeability in Sf9 cells. These cul-
tured insect cells have proven to be particularly useful for
studying the formation and properties of channels induced by
B. thuringiensis toxins (49, 52, 53), and their high sensitivity to
Cry1C has been shown to correlate with specific binding to a
40-kDa plasma membrane protein (26). Domain II from a
toxic parental protein is clearly required for activity, but it is
not sufficient and must interact properly with domain I for the
chimeras to be active. Exchange of domain III can lead to an
increase in toxicity, whereas exchange of domain I may result
in total loss of toxicity. The size of the pores was also affected
by the exchange of domain I but was unrelated to the level of
toxicity.
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MATERIALS AND METHODS
Bacterial strains and plasmids. Escherichia coli DH5a and crystal-negative B.
thuringiensis subsp. kurstaki HD1 Cry2 B were used as host strains for transfor-
mation. pAlter-1 (Promega) was used for site-directed mutagenesis. pHT3101
was used as an E. coli-B. thuringiensis shuttle vector (30). cry1C from B. thurin-
giensis subsp. entomocidus 60.5, cry1E from B. thuringiensis subsp. kenyae 4F1,
and cry1Ac from B. thuringiensis subsp. kurstaki HD1 were subcloned from
plasmids p60.5G31 (54), pEM14 (55), and pMP37 (36), respectively.
Molecular techniques. Standard recombinant DNA techniques were used as
described by Sambrook et al. (41). DNA fragments containing the B. thuringiensis
cry1Ac, cry1C, and cry1E toxin genes were subcloned into pAlter-1 prior to
oligonucleotide-mediated site-directed mutagenesis conducted by using the Al-
tered Sites II kit (Promega). Mutated clones were analyzed by DNA sequencing
by using the chain termination technique (42) in an Applied Biosystems 370A
nucleotide sequence analyzer. DNA and protein sequence alignments were ob-
tained through the CLUSTAL method by using the Megalign software from the
DNAStar package.
Construction of chimeric genes. The structures of the toxins used in the
present study are represented schematically in Fig. 1. Construction of the chi-
meras EEC (G27), CCE (F26), AbAbC (H04), and CCAb (H205) has been
described previously (3, 10, 11). The AbCC hybrid (H2C5) was selected after in
vivo recombination from the cry1Ab-cry1C tandem plasmid pRM7 (10). These
chimeric genes were expressed in E. coli XL-1 blue, and the proteins were
purified as described previously (3, 10, 11). Domain I chimeras AcCC, CEE, and
ECC were constructed by exchanging domain I at the level of the highly con-
served QLTRE sequence separating domain I from domain II as shown by the
three-dimensional structure of Cry1Aa (18). An XhoI site was created by mu-
tagenesis of codons 264 and 265 (264ACA AGA GAA3264ACT CGA GAA
[XhoI site underlined]) of cry1Ac and codons 263 and 264 (263ACA AGG
GAA3263ACT CGA GAA [XhoI site underlined]) of cry1C and cry1E. Mu-
tagenesis and frame conservation were verified by DNA sequencing prior to
cloning. This XhoI site was located over similar codons in cry1Ac, cry1C, and
cry1E, thus allowing the replacement of the domain I coding region without any
frameshift. In addition, this mutagenesis did not change the amino acid sequence
of the toxin and the resulting chimeric proteins therefore carried a QLTRE
bridge identical to that of the parental proteins. By use of a unique SacI site
located upstream from the promoter region in cry1Ac, cry1C, and cry1E along
with the newly created XhoI site, an XhoI-SacI fragment containing the region
encoding domain I and the first 28 amino acids of the protoxin, as well as the
promoter sequence, was generated. The cry1Ac-cry1C (AcCC) chimeric gene was
constructed by replacing the XhoI-SacI fragment of the mutated cry1C gene with
the corresponding XhoI-SacI fragment from the mutated cry1Ac gene. Similarly,
the chimeric cry1C-cry1E (CEE) and cry1E-cry1C (ECC) genes were constructed
by replacing the XhoI-SacI fragment from the mutated cry1E and cry1C genes
with that from the same mutated cry1C and cry1E genes, respectively. The
chimeric cryAc-cry1C (AcCC), cry1C-cry1E (CEE), and cry1E-cry1C (ECC) genes
were transferred to the shuttle vector pHT3101 (30) and expressed in a crystal-
negative B. thuringiensis strain.
Electroporation of B. thuringiensis cells. Transformation was performed as
described by Lereclus et al. (30). Electroporated cells were plated onto solid
brain heart infusion medium with erythromycin (25 mg/ml). The presence of the
expected construct in selected recombinant B. thuringiensis strains was verified by
extracting B. thuringiensis plasmid DNA and transforming E. coli with the ex-
tracted DNA. Recombinant E. coli strains were selected with erythromycin as for
screening of recombinant B. thuringiensis strains. Plasmid DNA was extracted
from E. coli and mapped with restriction enzymes. Maps were compared to those
of similar constructs extracted from the original recombinant E. coli strains
obtained prior to electroporation of B. thuringiensis.
Purification of parasporal inclusions. A 125-ml liquid culture, on the “usual
medium” of de Barjac and Lecadet (9) supplemented with glucose and erythro-
mycin, was inoculated with 2.5 ml of an overnight preculture and grown at 28°C
under vigorous agitation until complete lysis, as monitored by light microscopy.
Cultures were harvested by centrifugation, and parasporal inclusion bodies were
purified as described previously (22). Protein concentration was determined by
the method of Bradford (4).
Solubilization and activation of protoxins. Inclusion bodies were solubilized
and protoxins were activated as described previously (13). Activated toxins were
centrifuged at 14,000 3 g for 30 min at 4°C, and the supernatant was purified by
low-pressure liquid chromatography through a Q-Sepharose anion-exchange col-
umn (Pharmacia) equilibrated with 40 mM Na2CO3, pH 10.7. Activated toxins
were eluted with a 50-to-500 mM NaCl gradient. Fractions containing the eluted
proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. They were dialyzed for 48 h at 4°C against sterile double-distilled water,
and precipitated protein was lyophilized.
Cell cultures. Sf9 cells (ATCC CRL 1711) were grown at 27°C in Grace’s
insect cell culture medium (Gibco) supplemented with 350 mg of sodium bicar-
bonate per liter, 3.33 g of yeastolate (Difco) per liter, 3.33 g of lactalbumin
hydrolysate (Difco) per liter, 50 mg of sodium ampicillin (Gibco) per liter, and
10% (vol/vol) heat-inactivated fetal bovine serum (Gibco). Cultures (100 to 150
ml) were grown in spinner flasks inoculated with 1.0 3 105 cells/ml with constant
stirring at 50 to 60 rpm. Experiments were carried out with cells in the midloga-
rithmic phase of growth.
Solutions. Osmotic-swelling experiments were carried out with 50 mM KCl–21
mM NaCl–14 mM MgCl2–11 mM MgSO4–6.8 mM CaCl2–3.9 mM glucose–2.2
mM fructose–120 mM sucrose–10 mM piperazine-N,N9-bis(2-ethanesulfonic
acid) (PIPES)-Tris, pH 6.5 (G* medium) (51). The composition of this medium
was modified as required for individual experiments by either replacing the KCl
with 50 mM N-methyl-D-glucamine hydrochloride, increasing the KCl concen-
tration from 50 to 100 mM, or adding 100 mM glucose, sucrose, or raffinose. The
osmolarity of all solutions was measured with a DigiMatic model 3D2 osmometer
(Advanced Instruments) and adjusted with sucrose.
Viability assays. The viability of Sf9 cells was evaluated by determining their
ability to exclude trypan blue after different periods of exposure to the toxins.
Cell culture aliquots were incubated at room temperature (24°C) with gentle
agitation in the presence or absence (controls) of 50 mg of toxin per ml. Samples
(80 ml) of the cell suspension were then mixed with 20 ml of 0.4% (wt/vol) trypan
blue and mounted immediately in the counting chamber of a hemocytometer.
Over 200 cells were counted in duplicate for each sample, and the proportion of
cells remaining translucent was taken as a measure of cell viability.
Intracellular pH measurements. Intracellular pH was monitored in individual
cells with a previously described microspectrofluorimetric technique (51, 52),
with slight modifications. The PIPES-Tris concentration of the medium was
increased from 10 to 50 mM. Cells were loaded by incubation with a 5 mM
concentration of the membrane-permeant acetoxymethyl ester derivative of 2,7-
bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF) (Molecular Probes) in G*
medium for 20 min at room temperature and rinsed with BCECF-free G*
medium. Experiments were carried out at room temperature in a custom-made
coverslip holder fitted to the stage of a Zeiss inverted microscope coupled to a
Spex CMIII spectrofluorimeter. Fluorescence intensities were measured at ex-
citation wavelengths of 450 and 500 nm and an emission wavelength of 530 nm.
Intracellular pH was calculated from the ratio of the fluorescence intensities
measured at 500 and 450 nm as described earlier (51, 52).
Video imaging analyses. Osmotic volume changes of individual Sf9 cells were
analyzed as described previously (53). Briefly, cells were observed under 3150
magnification with an Olympus IMT-2 inverted microscope. Images were re-
corded every 1 s with a monochrome CCD-72 camera (DAGE-MTI) connected
to a 486 DX2 PC computer equipped with an IP8/AT videographics system board
(Matrox). The surface area occupied by each cell was measured, and the cellular
volume was estimated with a program made by us.
RESULTS
Influence of domain exchange on cell viability. The activities
of the various toxins were first tested with a trypan blue exclu-
sion viability assay (Fig. 2). Among the parental toxins (Fig.
2A), only Cry1C was strongly active against Sf9 cells, killing
FIG. 1. Schematic representation of the domain compositions of the parental
and hybrid toxins used in this study. The names originally given to previously
described hybrid toxins are in parentheses (3, 10).
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over 85% of the cells after 2 h of incubation. A slight sensitivity
to Cry1Ac was observed after prolonged incubation, however,
with about 20% mortality after 5 h. The viability of cells incu-
bated with Cry1Ab and Cry1E, on the other hand, was not
significantly affected in comparison with that of controls incu-
bated without toxin. Of the Cry1Ab-Cry1C and Cry1Ac-Cry1C
hybrids, only those containing domain II from Cry1C were
active (Fig. 2B). The toxicity of AbCC and AcCC was compa-
rable to that of Cry1C, whereas AbAbC had no detectable
activity and CCAb was more highly toxic, killing over 95% of
the cells within 1 h. In contrast, among the Cry1C-Cry1E hy-
brids, only CCE was strongly active against Sf9 cells, causing
above 90% mortality after 2 h (Fig. 2C). ECC, another toxin
which contained domain II from Cry1C, was inactive along
with EEC and CEE (Fig. 2C).
Effects of chimeric proteins on intracellular pH variations.
As was shown previously, the intracellular pH of Sf9 cells is
strongly dependent on the extracellular K1 concentration (51).
Removal of this ion from the external medium resulted in
reversible acidification of the cells (Fig. 3A) due to the pres-
ence of a strong K1-H1 exchange activity in the plasma mem-
brane (51). In the presence of an active toxin, such as the
AcCC hybrid, the intracellular pH equilibrated with that of the
FIG. 2. Effects of parental and chimeric toxins on the viability of Sf9 cells.
The cells were grown in Grace’s insect cell culture medium. Their viability was
evaluated by determining their ability to exclude trypan blue after different
periods of exposure to 50 mg of the indicated parental toxins per ml. (A)
Symbols: F, control; n , Cry1Ab; , Cry1Ac; , Cry1C; }, Cry1E. (B) Cry1Ab-
Cry1C and Cry1Ac-Cry1C hybrids. Symbols: F, control; n , AbCC; , AbAbC; ,
CCAb; }, AcCC. (C) Cry1E-Cry1C hybrids. Symbols: F, control; n , CEE; ,
ECC; , EEC; }, CCE. The data are means 6 the standard errors of the means
of three experiments, each done in duplicate.
FIG. 3. Effect of the extracellular K1 concentration on the intracellular pH
(pHi) of Sf9 cells. Sf9 cells were preincubated for 15 min without (A) or with (B)
25 mg of the AcCC chimeric toxin per ml in G* medium containing 50 mM KCl
at pH 6.5. The bath was rinsed with toxin-free G* medium, and the intracellular
pH was monitored for 5 min. Extracellular KCl was then replaced with N-methyl-
D-glucamine–HCl for another 10 min, after which the cells were returned to G*
medium. The traces shown are representative of five experiments.
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medium, i.e., 6.5 (Fig. 3B). The cell acidification resulting from
removal of external K1 was transient, and the pH returned
rapidly to its original level. Restoration of the extracellular K1
caused an alkalinization of the cells which was also transient.
Experiments similar to that illustrated in Fig. 3B were car-
ried out to evaluate the ability of the parental and chimeric
toxins to abolish pH gradients across the plasma membrane of
Sf9 cells (Fig. 4). Only toxins which were strongly active in the
trypan blue exclusion assay (i.e., Cry1C, AbCC, CCAb, AcCC,
and CCE) caused the pH to equilibrate across the plasma
membrane, both in the presence and in the absence of extra-
cellular K1 (Fig. 4). With any of the other toxins, the intracel-
lular pH remained between 6.23 and 6.35 in the presence of
K1 and stabilized at about 5.9 after removal of K1, as was
observed in the absence of toxin (Fig. 4).
Permeability of the pores induced by parental and chimeric
proteins. The effects of the different toxins on the plasma
membrane permeability of Sf9 cells were further analyzed with
a recently described video imaging technique (53). Cells were
preincubated for 15 min in G* medium with either nothing
(controls) or one of the toxins, and the KCl concentration of
the medium was rapidly raised from 50 to 100 mM. In the
absence of toxin, this hypertonic shock caused Sf9 cells to
shrink by 8 to 12% of their original volume (Fig. 5A). This was
also observed with the inactive toxins Cry1Ab, Cry1Ac, Cry1E
(Fig. 5A), AbAbC (Fig. 5B), EEC, CEE, and ECC (Fig. 5C).
The active toxins Cry1C, AbCC, AcCC, CCAb, and CCE, on
the other hand, allowed KCl to diffuse across the plasma mem-
brane, and the cells rapidly recovered their original volume
(Fig. 5). In the presence of the relatively high toxin concentra-
tion used in these experiments (10 mg/ml), the permeability to
KCl was, in fact, sufficiently high to completely abolish the
effect of the hypertonic shock with most of the active toxins
(Fig. 5).
To estimate the sizes of the pores formed by the active
chimeras, a comparison of toxin-induced permeability to vari-
ous sugar molecules was done (Fig. 6). Cells exposed to Cry1C
(Fig. 6B) and CCAb (Fig. 6D) became permeable to glucose
and sucrose but remained impermeable to raffinose. CCE (Fig.
6F) allowed the diffusion of glucose but did not increase the
permeability of the membrane to sucrose. Finally, whereas
cells preincubated with AbCC (Fig. 6C) and AcCC (Fig. 6E)
became highly permeable to KCl, those exposed to AbCC, in
contrast with those exposed to AcCC, acquired a slight per-
meability to glucose, evidenced by the fact that their volume
stabilized at a higher level than that of control cells (Fig. 6A)
(53). Based on the hydrodynamic radii of these sugar mole-
cules (25, 45), the diameters of the pores formed by Cry1C and
CCAb are between 1.0 and 1.2 nm and those of the pores made
by AbCC and CCE are between 0.8 and 1.0 nm. The pore
generated by AcCC has a diameter of less than 0.8 nm.
DISCUSSION
Results of the present study stress the importance of domain
II in the specificity of B. thuringiensis Cry toxins, in agreement
with previous reports (see the introduction). However, they
also provide evidence of interactions essential for toxin activity.
Sf9 cells were sensitive to only one of the parental toxins,
Cry1C, and all hybrid proteins that were active had domain II
of this toxin. A similar conclusion was drawn from the results
obtained with all three of the techniques used to characterize
the different toxins. Nevertheless, the presence of domain II
from Cry1C was not sufficient to confer activity against Sf9 cells
on the hybrid proteins, as evidenced by the inactivity of the
ECC hybrid. The reason for this apparent incompatibility be-
tween domain I from Cry1E and the rest of the molecule from
Cry1C remains to be established. It suggests, however, that
interactions between domain I and the other two domains are
probably important for the activity of the toxin. Since a thor-
FIG. 4. Effects of parental and chimeric toxins on the intracellular pH (pHi)
of Sf9 cells. Sf9 cells were preincubated with 25 mg of the indicated parental
toxins per ml (A), Cry1Ab-Cry1C and Cry1Ac-Cry1C hybrids (B), or Cry1E-
Cry1C hybrids (C). Intracellular pH was recorded in experiments similar to those
illustrated in Fig. 3 in the presence of KCl (open bars) and 10 min after replace-
ment of the medium with a K1-free solution (hatched bars). The extracellular
pH was 6.5 throughout the experiments. The data are means 6 the standard
errors of the means of five experiments.
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ough effort was made to avoid the introduction of additional
changes within the hinge region separating domains I and II, as
well as within the domains themselves, these data suggest that
the lack of activity of ECC is related to a structural incompat-
ibility of domain I from Cry1E and domains II and III from
Cry1C. A number of interdomain salt bridges and hydrogen
bonds have been identified in the crystal structure of Cry1Aa
(18). It remains to be seen whether this incompatibility is due
to the absence of some of these interactions or whether new
interactions which interfere with toxin activity were generated
in ECC.
Further evidence of functional interactions between the dif-
ferent toxin domains was obtained from the comparison of the
sizes of the pores formed by the different hybrid proteins. Pore
size depended, in part, on the toxin from which domain I
originated. The pores formed by AbCC (diameter, 0.8 to 1.0
nm) and AcCC (diameter, ,0.8 nm) were smaller than those
formed by Cry1C (diameter, 1.0 to 1.2 nm). However, it is
uncertain whether the smaller size of the pores formed by
AbCC and AcCC reflects the properties of Cry1Ab and
Cry1Ac since the sizes of the pores formed by very few B.
thuringiensis toxins have been reported. Cry1Ac has neverthe-
less recently been shown to form much larger pores (diameter,
2.4 to 2.6 nm) which allow the diffusion of raffinose and various
polyethylene glycol molecules into Manduca sexta brush border
membrane vesicles (6). Although this comparison may suggest
a strong influence of domains II and III on the size of the pores
formed by AcCC, the possibility cannot be excluded that the
properties of the pores formed by B. thuringiensis toxins also
depend on the membrane receptor to which they bind (24, 53).
The sizes of the pores formed by given toxins could therefore
differ, depending on the biological membrane in which they are
formed. Unfortunately, the inactivity of Cry1Ab and Cry1Ac
toward Sf9 cells precludes a direct comparison of the proper-
ties of the pores formed by AbCC and AcCC with those
formed by the parental toxins in these cells. On the other hand,
the size of the pores can clearly be affected by domain III since,
in contrast to Cry1C and CCAb, which allowed rapid diffusion
of sucrose, CCE allowed, at best, very poor diffusion of this
molecule.
Although differences in the sizes of the pores formed by
different toxins were readily detected, these differences did not
appear to be directly related to toxicity, at least at the relatively
high doses used in the present study, since Cry1C, AbCC,
AcCC, and CCE killed Sf9 cells at similar rates. On the other
hand, even though Cry1C and CCAb had similar pore sizes,
CCAb was clearly more active than Cry1C. The level of toxicity
therefore appears to be more strongly affected by the number
of pores formed by a given toxin than by relatively small dif-
ferences in pore size such as those reported here.
Several cases in which substitution of domain III increased
the toxicity of a B. thuringiensis toxin have been reported pre-
viously (3, 10, 11, 29, 35). For example, EEC is highly toxic to
Spodoptera exigua and Mamestra brassicae larvae even though
these insects are not sensitive to Cry1E (3). Similarly, AbAbC
is much more active against S. exigua than is Cry1Ab (10).
Although the presence of domain III from Cry1C was insuffi-
cient to confer activity against Sf9 cells on these hybrid pro-
teins, it remains probable that the CCAb hybrid can bind to
another receptor in addition to that which recognizes Cry1C,
even though Sf9 cells have repeatedly been reported to be
insensitive to Cry1Ab (52, 53). Previous ligand blot studies
have indeed revealed that CCAb appears to bind to one of the
proteins which bind Cry1Ab in brush border membrane vesi-
cles of S. exigua but to a different minor Cry1Ab-binding pro-
tein in those of M. sexta (10, 11). Further work is required,
however, to establish whether a similar mechanism operates in
Sf9 cells.
In agreement with a number of studies involving mutagen-
esis of cry genes (see the introduction), the results of the
present study indicate that relatively minor modifications of
the primary structures of the toxins can lead to considerable
changes in their properties. AbCC formed slightly larger pores
than did AcCC despite the fact that Cry1Ab and Cry1Ac have
FIG. 5. Video imaging analysis of the pore-forming abilities of parental and
chimeric toxins in Sf9 cells. The cells were preincubated for 15 min with 10 mg of
the indicated parental toxins per ml (A), Cry1Ab-Cry1C and Cry1Ac-Cry1C
hybrids (B), or Cry1E-Cry1C hybrids (C). Pore formation was assessed from the
rate of osmotic swelling of the cells. These were submitted to a hypertonic shock
by replacement of the bathing solution with a solution with a similar composition
but enriched with 50 mM KCl. Cell volume was recorded every 1 s. The data are
means 6 the standard errors of the means of four to eight experiments. For
clarity, error bars are shown at every 10th experimental point.
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almost identical primary structures in domain I. In addition,
because Cry1Ac and Cry1E are highly homologous in domain
I, 90% of the amino acid residues are identical in AcCC and
ECC. Nevertheless, the pore-forming ability of AcCC was
comparable to that of Cry1C whereas ECC was completely
inactive.
Although this study provides further support for the notion
that domain I is directly involved in pore formation and do-
mains II and III play a critical role in specificity, it also dem-
onstrates that the toxicity, as well as the properties, of the
pores formed by the hybrid proteins cannot be simply pre-
dicted from the properties of the toxins from which the differ-
ent domains being combined originated.
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FIG. 6. Estimation of the sizes of pores formed by B. thuringiensis toxins in the plasma membrane of Sf9 cells. Sf9 cells were preincubated for 15 min without toxin
(A) or with 10 mg of Cry1C (B), AbCC (C), CCAb (D), AcCC (E), or CCE (F) per ml. They were submitted to a hypertonic shock by replacement of the bathing solution
with a solution with a similar composition but enriched with either 50 mM KCl or 100 mM glucose (Glc), sucrose (Suc), or raffinose (Raf). Cell volume was recorded
every 1 s. The data are means 6 the standard errors of the means of four to eight experiments. For clarity, error bars are shown at every 10th experimental point. The
estimated pore diameters were 1.0 to 1.2 nm for Cry1C and CCAb, 0.8 to 1.0 nm for AbCC and CCE, and less than 0.8 nm for AcCC.
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